20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3124 | Carbendazim | Bavistin,Carbendazole,Mercarzole | Antifungal |
Carbendazim (Mercarzole) is a broad-spectrum benzimidazole antifungal with potential antimitotic and antineoplastic activities. Although the exact mechanism of action is unclear, carbendazim appears to binds to an unspec... | |||
T26978 | CEP-40125 | RXDX-107 | DNA Alkylation |
CEP-40125 (RXDX-107) is a DNA alkylating agent for the study of advanced solid tumors. | |||
T79157 | Pimicotinib | ABSK021,ABSK-021 | c-Fms , Others |
Pimicotinib (ABSK021) is a potent CSF1R inhibitor with antitumor activity and can be used to study advanced solid tumors. | |||
T36395 | Trotabresib | CC-90010 | Epigenetic Reader Domain |
Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors. | |||
T2113 | PHA-793887 | PHA 793887,PHA793887 | Apoptosis , CDK |
PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors. | |||
T76706 | Varlilumab | CDX-1127 | TNF |
Varlilumab (CDX-1127) is a novel human IgG1 anti-CD27 monoclonal antibody. Varlilumab has antitumor activity and can be used to study advanced solid tumors. | |||
T40199 | Tulmimetostat | CPI-0209 | Histone Methyltransferase |
Tulmimetostat (CPI-0209) is an orally active EZH1/EZH2 inhibitor.Tulmimetostat has antitumor activity and is used in the study of ovarian cancer and advanced solid tumors. | |||
T77750 | Rosmantuzumab | OMP-131R10 | Others |
Rosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3). Rosmantuzumab has potential antitumor activity and can be used to study advanced relapsed refractory solid tumors. | |||
T77138 | Ragifilimab | INCAGN-01876,INCAGN-1876,CM-701 | TNF |
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting glucocorticoid-induced TNFR-associated protein (GITR). Ragifilimab can be used in the study of advanced or metastatic solid tumors. | |||
T83970 | IMMH 010 maleate | YPD-30 maleate | PD-1/PD-L1 |
IMMH 010 maleate (YPD-30 maleate) is an orally available programmed cell death ligand 1 inhibitor with potential antitumor activity for the study of neurological disorders and advanced malignant solid tumors. | |||
T2709 | TAK-901 | TAK901 | JAK , CDK , Src , Aurora Kinase |
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others. | |||
T6084 | Rabusertib | LY2603618,IC-83 | Chk , PDK , Autophagy |
Rabusertib (IC-83) is an inhibitor of the cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiating activity. Rabusertib has been used in trials studying the treatment of Cancer, Solid Tumors, Advanced Cance... | |||
T6157 | Devimistat | CPI-613,CPI613,CPI 613,6,8-Bis(benzylthio)octanoic acid | Apoptosis , Dehydrogenase , Mitochondrial Metabolism |
Devimistat (6,8-Bis(benzylthio)octanoic acid) , a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism. It has potent... | |||
T0078L | Lapatinib ditosylate monohydrate | Lapatinib ditosylate monohydrate,Lapatinib ditoluenesulfonate monohydrate,Lapatinib tosilate hydrate,Lapatinib tosilate,Tykerb,Tyverb | EGFR , Ferroptosis , Autophagy |
Lapatinib ditosylate (Lapatinib tosilate) monohydrate is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib ditosylate monohydrate therapy is associated w... | |||
T11500L | GSK3368715 dihydrochloride | EPZ019997 dihydrochloride,GSK3368715 2HCl,EPZ019997 2HCl | Histone Methyltransferase |
GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active and potent inhibitor of type I protein arginine methyltransferases (PRMTs) with anticancer and antitumor activity, inhibiting PRMT1, PRMT3, PRMT4... | |||
T76787 | Conatumumab | TRAIL-R2 mAb,AMG 655 | TNF |
Conatumumab (AMG 655) is a monoclonal agonist antibody targeting human death receptor 5 (DR5, TRAILR2) at Kd 1 nM for long DR5 and Kd 0.8 nM for short DR5. Conatumumab induces apoptosis in a variety of tumor types throug... | |||
T24176 | (-)-Irofulven | MGI-114,NSC-683863,MGI 114,HMAF,MGI114,Irofulven | |
Irofulven is an agent of DNA-damaging and antitumor. It is used for the treatment of advanced solid tumors, including prostate, ovarian, and pancreatic cancers. | |||
T77120 | Opucolimab | ||
Opucolimab, an anti-PD-L1 recombinant human monoclonal antibody, has applications in synthesizing antibody-agent conjugates and is utilized in research targeting advanced solid tumors [1]. | |||
T69759 | IACS-9439 | c-Fms | |
IACS-9439 is a potent, selective, and orally active inhibitor of CSF1R, exhibiting a K(i) of 1 nM. It is applicable in the research of advanced solid tumors [1]. | |||
T76929 | Betifisolimab | ||
Betifisolimab (MSB-2311), a humanized monoclonal antibody targeting the immunosuppressive ligand PD-L1, shows promise for research in advanced solid tumors and hematological malignancies [1]. |